Shares in Biocon slumped after earnings disappointed some investors. Biocon said on Wednesday its December-quarter consolidated net ...
Please click one of the button below to read Full Story / Video.
Shares in Biocon slumped after earnings disappointed some investors.
Biocon said on Wednesday its December-quarter consolidated net profit rose 14 percent to R
s.
105 crore.
Some analysts cited disappointment over operating margins, with Kotak Institutional Equities expressing concerns about research and development margins.
"R&D margin at 2.9 per cent is the lowest in the past several quarters, which raises concerns on sustainability of the margin improvement," it said in a report.
Investors are also locking profits after the stock jumped 8.5 per cent in the previous three sessions.
Biocon shares were trading down 5.2 per cent at 3 p.m.
Sponsored Links
Like us For more Updates
0 comments:
Post a Comment